Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 20

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

246

HTML

2109

Figures (1-1)

202

Tables (1-2)

195

Sum=2752

May 28, 2007 (publication date) through Nov 30, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. May 28, 2007; 13(20): 2852-2854
Published online May 28, 2007. doi: 10.3748/wjg.v13.i20.2852

Table 2 Major toxicity

Toxicity	%
Anemia grade 3/4	31/2
Neutropenia grade 3/4	19/2
Thrombocytopenia grade 3/4	5/0
Nephrotoxicity (Creatinine) grade≥2	0
Nausea/vomiting grade≥2	0
Neuropathy grade≥2	0
AST/ALT grade≥2	0

Citation: Charoentum C, Thongprasert S, Chewaskulyong B, Munprakan S. Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma. World J Gastroenterol 2007; 13(20): 2852-2854
URL: https://www.wjgnet.com/1007-9327/full/v13/i20/2852.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i20.2852